Eyerising International is proud to introduce repeated low-level red-light therapy for slowing the progression of childhood myopia through the Eyerising Myopia Management Device. The device is non-invasive, available for children aged 3-16, and can be used either as monotherapy or in combination wit... Read more
Org chart
Collapse
No reports!
Teams
This company has no teams yet
Offices
This company has no offices yet
